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Expression of the CD4 glycoprotein, the surface receptor for the human im-
munodeficiency virus(HIV) (1-4), andofspecific transcription factorsthat promote
the expression of HIV genes (5) are characteristics that target a subset of lympho-
cytes for the pathological consequences ofHIV infection. Additional properties of
CD4+ lymphocytes and other HIV host cells could affect the efficiency ofreplica-
tion or the cytopathic effects ofthe virus, and thereby determine whether the out-
come ofinfection is cell death; the establishment ofa latent, nonproductive state;
or theevolution ofa chronic, virus-producingreservoir. The existence andpotential
importance of such host cell-specific factors is suggested by the variable response
to HIV infection among cultured human lymphoid cell lines in vitro (6-8). The
basis forthis variability is poorly understood, and thespectrumofresponsesto HIV
infection in vitro has not been well characterized.
The regulation ofdeoxyribonucleotide pool size and turnover in host cells could
affect the reverse transcription of the HIV genome and subsequent replication of
double-stranded circular viral DNA, and could strongly influence the therapeutic
activity orcytotoxicityofantiretroviral nucleoside analogs. Inview ofthese possibil-
ities, we initiated studies ofthe ability ofHIV to infect mutant lymphoblastoid cell
lines with altered nucleoside metabolism. We chose the CEM human T cell line
(9) and the WIL-2 human B cell line (10) because they have been shown to differ
strikingly in their regulation of deoxynucleotide metabolism (11, 12), and because
of the availability ofmutants ofeach that are deficient in specific nucleoside kinase
activities, which could be useful for studies of antiretroviral nucleoside analog me-
tabolism. Here we report asystematic characterization ofthe responses ofthese mu-
tants and other derivatives of CEM and WIL-2 to infection with the HTLVIIIB
strain of HIV.
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Materials and Methods
Cell Line Selection and Culture Methods.
￿
The strain of CEM used in this laboratory was ob-
tained from Dr. Peter Creswell, Duke University. CEM4, a subclone of this strain, was used
as wild type in the studies described in this report. CEM/3B, used as the HIV donor in cell
fusion assays (see below), is a derivative of this strain of CEM that has been chronically in-
fected with HTLVIIIB (13). An independently maintained wild-type CEM strain and its
deoxycytidine kinase-deficient (dCK-)' derivative (14) were kindly made available by Dr.
A. Fridland, St. Jude Children's Research Hospital. The nucleoside kinase-deficient mu-
tants of CEM Ml-la (adenosine kinase-deficient, AK- ), AC0611a (dCK- ), and RC3b
(doubly deficient in AK and dCK) have previously been described (11); in addition to their
AK- and dCK-deficient phenotypes, each ofthese lines also lacks hypoxanthine-guanine phos-
phoribosyltransferase (HPRT) activity.
The following mutants ofthe WIL-2 human splenic, EBV' B lymphoblastoid cell line were
studied: 107 (AK- ) (15, 16) ; a dCK- mutant (17) referred to as BdCK (obtained from B.
Ullman, Oregon State University for the Health Sciences, OR); and an AK- dCK- double
mutant derived from 107 (17), referred to as K2B. Additional independent AK- dCK- de-
rivatives ofWIL-2, not previously described, were isolated by stepwise selection in the pres-
ence of 10 gM 6-methylmercaptopurine ribonucleoside (6-MMPR; Sigma Chemical Co.,
St. Louis, MO) and 1 gM arabinosylcytosine (ara-C; Sigma Chemical Co.), cytotoxic sub-
strate analogs ofAK and dCK, respectively. The clones isolated by these selections had <1-3 %
of the AK and dCK activity found in WIL-2. Assay conditions for measurement of AK and
dCK activities in cell extracts have been described (11). After initial screening for sensitivity
to HTLVIIIB (see below) one of these AK- dCK- mutants, termed AA, was subcloned and
studied further.
All cell lines were cultured in RPMI 1640 (Gibco Laboratories, Grand Island, NY) sup-
plemented with 10% heat inactivated FCS (Gibco Laboratories), nonessential amino acids,
2 mM glutamine, and 1 mM pyruvate, under 5°Jo C02 in air at 37°C. Subclones of wild-
type and mutant T and B cell lines were obtained by limiting dilution cloning in 96-well
culture plates at 0.2 and 0.5 cells per well in this growth medium with the addition of 10%
horse serum (Gibco Laboratories) and any selective drugs. The phenotypes ofwild-type and
mutant cell lines were routinely confirmed every 2-3 mo by evaluating resistance/sensitivity
to 10 gM 6-MMPR (AK), 1 pM ara-C (dCK), and 10 gM 6-thioguanine (HPRT).
Cell Surface Antigen Expression.
￿
The percentage ofcells expressing lymphocyte cell surface
antigens was analyzed by indirect immunofluorescence and FACS using the following mAbs:
Leu-3a + Leu-3b (Becton Dickinson Monoclonal Center, Mountain View, CA) and OKT4
and OKT4A (Ortho Diagnostic Systems, Raritan, NJ), which detect epitopes of the CD4
(T4) antigen; anti-human HLA-DR (Becton Dickinson & Co.), directed against a class II
histocompatibility antigen; the 3A1 pan-T cell mAb, obtained from B. F Haynes, Duke Univer-
sity; BI and B4, markers ofmature and immature B cells (Coulter Immunology, Hialeah, FL).
106 cells were washed twice with PBS containing 1% BSA and 0 .1% sodium azide
(PBS(BSA/NaN3), and then were incubated with 1 :40 to 1 :200 dilutions of mAb for 30 min
at 4'C. After three washes with PBSBSA/NaN3, cells were incubated for 30 min at 4°C with
a 1 :50 dilution ofaffinity-purified FITC-conjugated goat anti-mouse IgG (Tago Inc., Burlin-
game, CA). After three washes, cells were resuspended in PBS/BSA/NaN3, fixed by the ad-
dition of 37% formaldehyde (10 ltl/ml of cell suspension), and stored in the dark for later
analysis. Background fluorescence was determined by incubating cells with P3 x 63/Ag/8
ascitic fluid (control murine myeloma protein, provided by B. E Haynes). Membrane staining
was assessed by FACS analysis of 10,000 cells, performed on a flow cytometer (EPICS 753;
Coulter Electronics, Hialeah, FL) .
Virus.
￿
Stocks of HIV strains HTLVIIIB, MN, and RF (18, 19) prepared from medium
of chronically infected H9 cells were kindly provided by Dr. A. Langlois, Duke University.
Preparation of virus stocks and titration of virus have been described (20).
' Abbreviations used in this paper AK- , adenosine kinase-deficient; dCK- , deoxycytidine kinase-
deficient; HPRT, hypoxanthine-guanine phosphoribosyltransferase.CHAFFEE ET AL.
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VirusInfection: Standard Protocol.
￿
Exponentially growing cells were pelleted and resuspended
in fresh medium at 105 cells/ml. Duplicate 10-ml aliquots (106 cells) were distributed in cul-
ture flasks, one of which was infected with 1 ml of a 1 :10 dilution of the virus stock (esti-
mated at _2 x 104 infectious units/ml, undiluted). 24 h after virus addition, the cells were
centrifuged and resuspended in 10 ml of fresh medium. Centrifugation and replacement of
medium was repeated every 24 h for the next 10-12 d, and every 2-3 d thereafter for the
course of the experiment. Cultures were diluted to 105 cells/ml in fresh medium every 3-5
days to permit continuation of exponential growth by still viable cultures. Depending upon
the rate of infection, viable cell count (trypan blue exclusion) and virus production were as-
sessed every 24-72 h by measuring virion-associated reverse transcriptase (RT) activity (19,
20) or amount of p24 protein in culture medium (p24 was determined either by RIA [NEK-
040; E. I. DuPont de Nemours & Co., Wilmington, DE] or by ELISA [NEK-041; E. I. DuPont
de Nemours & Co.]. Cultures were monitored untilthe HIVexposed cells exhibited acytopathic
effect or until no cytopathic effect had been observed for 12-15 d. A cell line was considered
to be permissive ifit supported the production ofRT at more than five times the background
for the assay. Sensitivity to virus cytopathic effect was determined by inspection and by com-
paring viable cell count of infected cultures to a parallel culture of the uninfected cell line.
A similar protocol was followed for studies of infection by the RF and MN isolates of HIV.
In some experiments susceptibility to infection was assessed at various times after cells
were exposed to serial dilutions of a standard virus stock, or after infection was carried out
in the presence of specific mAbs. Details of these experiments are described in the text and
figure legends.
Syncytium Fornu:tion.
￿
As previously described (13, 21) 75 x 103 uninfected target cells were
combined in medium containing or lacking 5 ug/ml OKT4A mAb, with 5 x 103 CEM/3B
cells (CEM cells chronically infected with HTLVIIIB) in wells of a 96-well one-half area
microtiter culture dish. After incubation for 24 h entire wellswere inspected by inverted phase
microscopy and foci of giant cells were counted. Wells were scored according to the number
of giant cell foci according to the following scale: 0 = none; 1 +
￿
= 10 or less; 2 +
￿
= 10-20;
3+ = 20-30; 4+ = 30-40.
Binding of 'z5I gp120.
￿
Purified gp120 from HTLVIIIB was prepared as described (22).
Binding of gp120 to cells will be described elsewhere (Skinner, M., and T J. Matthews, manu-
script in preparation). Briefly, duplicate aliquots of 106 cells in 0.1 ml of medium (containing
or lacking 10 ug/ml of OKT4A mAb) were incubated for 30 min at room temperature with
_105 cpm Of 'z5I-gp120. The cell suspension was then layered over 0.3 ml of phthalate oil
in a 0.4 ml microcentrifuge tube and the cells were separated from unbound gp120 by cen-
trifugation for 30 s at 13,000 g. After careful aspiration of the overlying medium and oil,
radioactivity in the cell pellet was determined in a gamma counter.
Results
Sensitivity to Infection by Free Virus
After screening of a larger number of cell lines and clones derived from the CEM
T and WIL-2 B cell lines, a selected group ofwild-type and nucleoside kinase-deficient
lines (Table I) were evaluated in more detail for ability to support productive infec-
tion by the HIV strain HTLVIIIB and their susceptibility to the cytopathic effect
ofthe virus (Table II, Figs. 1 and 2). In these experiments, cell growth and viability
and production of RT were followed for at least 15 d on at least one occasion and
on other occasions for 10-15 d, depending on the characteristics of the particular
cell line.
CEM T Cells.
￿
The growth and viability of our wild-type strain of CEM declined
markedly by 7-10 d after infection; RT production by infected cells peaked after
_7-8 d . Similar results were observed with 10 of 11 randomly selected wild-type
subclones and with Ml-1a, an AK- derivatives of this CEM strain. In contrast to608
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TABLE I
Cell Line Characteristics
Cell line
￿
Nucleoside kinase phenotype
CEM strains
CEM
￿
Wild type
CEM 4
￿
Wild type
CEM (St. Jude)
￿
Wild type
dCK- (St. Jude)
￿
dCK-
AC0611 a
￿
dCK-
M I-1 a
￿
AK-
WIL-2 strains
WIL-2
￿
Wild type
BdCK
￿
dCK-
107
￿
AK-
K2B
￿
AK- -dCK-
AA clones (1-5)
￿
AK- -dCK-
wild-type CEM and M1-la, strain AG0611a, which lacks WK, was nonpermissive,
showingnochange in growth rate ordecrease in cellviability, andalmost noproduc-
tion of RT during 15 d after exposure to HTLVIIIB (Table II, Fig. 1). RC3b, an
AK- -dCK- double mutant derived from AC0611a (11), was also nonpermissive
(data not shown).
Ml-la and AC0611a were selected in different laboratories from independently
maintained strains of CEM. The sensitivity to HIV infection of the CEM parent
ofAC0611a is unknown. Thus, the HIV-resistant phenotype ofAC0611acould have
been a property ofits WK-expressingparent, rather than aconsequence ofthe loss
ofdCK activity. The former possibility is underscored by the finding that another
independently maintained CEM wild-type strain and a dCK- derivative selected
from it were both nonpermissive for HTLVIIIB (St. Jude strains, Table II). Since
dCK- cell lines derived from WIL-2 can be infected by HIV (see below), expres-
sion of dCK cannot be an absolute determinant of HIV sensitivity.
WIL-2 B Cells.
￿
Similar studies with nucleoside kinase-deficient variants of the
WIL-2 B cell line(Table II, Fig. 2) can be summarized as follows: (a)wild-typeWIL-2
cells and some cloned AK--dCK- derivatives ofWIL-2 supported essentially no
replication ofHTLVIIIB (data for the latter not presented) . (b) The cell lines 107
(AK-), BdCK (dCK- ) and some AK- -dCK- clones supported HTLVIIIB repli-
cation, with maximal RT production ocurring 6-8 d after infection. The level of
RT(also p24, see below) produced by 107 and BdCK approached that observed with
CEM in some experiments, but in others was 10-20% of the CEM values. In con-
trast to permissive strains ofCEM, infection by HTLVIIIB had minimal effect on
growth and viability of these derivatives ofWIL-2. (c) Five subclones (AAl-AA5)
ofthe AA (AK-dCK-) cell line were strikingly permissive for HTLVIIIB and sen-
sitive to itscytopathiceffects (representative resultsfor the AA2 subclone are reported
below). K2B, another AK--dCK- double mutant, was also permissive, but some-
what less sensitive to virus cytopathic effect.
Viable AA2 cells decreased to<10% ofanuninfected AA2 control cultureby 3-5
d after exposure to HTLVIIIB; RT production was maximal by day 3-5 and theCHAFFEE ET AL.
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TABLE II
Sensitivity to HIV Infection
Viable cell counts and RT activity were monitored daily for 12-15 d after infection with
HTLV-IIIB using the standard protocol (see Materials and Methods).
Onset ofcytopathic effect was the day when increase in viable cell count ceased. Syncytium
formation (see Materials and Methods) was monitored in a separate experiment (identical
results were obtained on two separate occasions).
level ofRT was comparable to that ofinfected, permissive CEM cells (Table II, Fig.
2). AA2 was in fact moresensitive than CEM to HTLVIIIB. This wasevidentwhen
virus production was determined as a function of multiplicity of infection. For ex-
ample, in the experiment presented in Fig. 3, p24 production was determined 5,
7, and 10 d after exposure ofAA2 and CEM4 cells to serial fourfold dilutions of
a standard HTLVIIIB stock (1:10 to 1 :164,000). With AA2, maximal production
of p24 was evident at every virus dilution on day 5. In contrast, with CEM4 sub-
maximal p24 production was detected only at the 1 :10 dilution of virus on day 5;
by day 10, p24 was detectable only through the first five dilutions (to 1 :2,560). A
more quantitative comparison of p24 production by AA2 and CEM4 is presented
below (Fig. 5). In addition to HTLVIIIB, AA2 supported replication ofHIV clin-
ical isolates, including MN and RF (23 and data not shown) .
Syncytium Formation
As another index of virus cytopathic effect, we evaluated the formation ofmul-
tinucleate syncytia within 24h afteruninfected celllineswere added in 15-foldexcess
to acultureofCEM/3B, a chronicallyinfected CEMlinethat continuously produces
low levels ofHTLVIIIB (Table II). HIV-sensitive CEM wild-type clones and MI-1a
were strongly positive in the fusion assay. No syncytia were observed with the non-
permissive strain AC0611a, but the HIV-resistant St. Jude wild-type and dCK-
strains ofCEM formed syncytia aseffectivelyas thepermissive CEM strains. Among
WIL-2 strains, Syncytium formation after exposure to CEM/3B was only observed
with the sensitive cell lines K2B and AA2, and fusion was less efficient than with
CEM strains that formed giant cells.
Cell lines
Cytopathic
effect"
Onset
Reverse
transcriptase
Maximum cpm
Syncitiom
formation
CEM derived
CEM day 8 353,320 (day 9) 4+
CEM4 day 8 565,810 (day 8) 3 +
M1-la day 9 553,567 (day 11) 4+
AC0611a None 3,500 0
CEM (St . Jude) None 3,890 4 +
dCK- (St. Jude) None 3,550 4 +
WIL-2 derived
WIL-2 None 1,500 0
BdCK None 59,000 (day 9) 0
107 None 103,790 (day 6) 0
K213 day 5-7 231,270 (day 6) 1 +
AA2 day 4-5 354,860 (day 4) 2 +610
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(A-D) Response of CEM-derived cell lines to infection with HTLVIIIB. The ex-
perimental procedureis as describedin the Materials andMethodsseciton. (left handpanels)Growth
(viablecell count) oftheindicateduninfected (opensymbols) andHTLVIIIB-infected (solidsymbols)
cell lines. (Right handpanels) Virion associated reversetranscriptase activity (RT) in culturemedium
in the same cultures shown on left. (A)CEM4, (B) Ml-lA, (C) AC0611a, (D) CEM wild type
(St. Jude).
Analysis of Cell Surface Markers
Over the 14-20-mo period during which their responses to HIV were studied,
we examined expression by the above celllines oftheCD4and DRclass II histocom-
patibility antigens on as many as six occasions; expression of other antigens was
evaluated less frequently (Table III). All of the CEM-derived cell lines expressed
a panel ofmarkers consistent with a T cell phenotype. DR was found on <12% of
cells, and the panT cell marker 3A1 (CD7) on 47-87%. 60-99% of cells reacted
with the Leu-3 and OKT4mAbs to CD4, and 43-99% reactedwith OKT4A. Small
fluctuations in thelevels ofexpression ofeachantigenwere observedfor eachcellline.
WIL-2 and its derivatives expressed cell surface markers consistent with a B cell
phenotype. DR was present on 75-95% ofcells, and <12% expressed the 3A1 T
cell marker. Except for AA2, expression of CD4 epitopes by these lines was uni-
formly low: 0-19% ofcells reacted with the Leu-3 and OKT4, and 0-7% with the
OKT4A mAb. Again, small fluctuations in the levels ofexpression were noted. Ex-
pression ofimmunologically detectable CD4 epitopes by the HIVsensitive cell line
AA2 (and other AA subclones) was considerably more variable, ranging from 1 to
6% on three occasions to 60 to 89% ofcells on three others. The kinetics ofHIV
infection and susceptibilityto cytopathic effect were essentiallyconstant during this
20-mo period, regardless of the level of CD4 expression (Table III, Table IV).
OKT4A Inhibition ofgp120 Binding and HTLV-IIIB Infection
The CD4 protein acts as a receptor for HIV by virtue ofthe specific interaction
between the OKT4A epitope of CD4 and the HIV envelope protein gp120 (1, 2,
4, 24-28). Thelow frequency ofCD4 expression by HIV-susceptible WIL-2-derived
cell lines, and conversely, the HIV insensitivity of some CEM derivatives that ex-612
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Response of WIL-
2-derived cell lines to infection
with HTLVIIIB. Details as de-
scribed in legend to Fig. 1, (A)
WIL-2, (B) BdCK, (C) 107, (D)
AA2 .1/virus dilution
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--.o-- AA2
- CEM4
pressed CD4 abundantly, prompted us to examine the OKT4A-inhibitablebinding
of purified, 1251-labeled gp120 by these cell lines (Fig. 4). In the absence ofantibody,
binding of 1251-gp120 correlated with the relative reactivity ofthe cell lines with an-
tibodies to the CD4 complex. Binding to CEM derivatives was inhibited 53-86%
byOKT4A. There was no detectable OKT4A-inhibitable gp120 bindingto WIL-2,
or to its HIVpermissive derivatives 107 and BdCK, which were resistant to HIV
induced fusion and expressed nearly undetectable levels of CD4. The amount of
gp120 bound by these cells was approximately equal to the level bound by CEM
TABLE III
Surface Antigen Expression
FIGURE 3.
￿
Production ofp24antigen by
CEM4 and AA2 cell lines infected with
dilutions of HTLVIIIB stock. Serial 1:4
dilutionswere prepared from a 1:10 start-
ingdilution ofastandard stockof HTLV
IIIB. 1-ml aliquots of cultures of CEM4
and AA2 (105 cells/ml) were inoculated
with 0.1 ml ofvirus-free diluent (control)
or with a dilution of virus (1 :10 to
1:164,000). On days 3 and5, 2 ml offresh
medium wasaddedto cultures, andon day
7, 3 ml was added. On days 5, 7, and 10,
0.4-mlsamples oftheculturemedium were
frozen forRIAanalysis ofp24. Forthep24
assay of day 5 AA2 samples, the culture
medium wasdiluted 1:10, whileforCEM4
(all days), theundilutedmedium samples
were assayed for p24.
Cell line
Leu-3'
Monoclonal
OKT4 OKT4A
Range of percent
antibodies
3A1 B1
of cells positive
B4 DR
CEM strains
CEM 78-96 60-92 88-95 71 4 4 0-12
CEM4 84-99 86-99 89-99 47 2 1 0-5
AC0611a 60-91 61-67 43-61 86 ND ND 0-10
Ml-la 81-84 85 81-85 87 ND ND 0-1
CEM St. Jude 71 66 69 ND ND ND 0
dCK- St. Jude 81 76 83 ND ND ND I
WIL-2 strains
WIL-2 0-14 0-15 0-3 0-3 57 29 83-90
BdCK 0-19 17 7 0 ND ND 83-93
107 0-2 0-9 0-2 4-11 65 46 84-95
K213 6-19 3-8 0-1 1 ND ND 76-94
AA2 6-82 1-68 1-63 1-2 80 4 75-95
Leu-3a + Leu-36614
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TABLE IV
CD4 Expression and Susceptibility to Infection by HTLV-IIIB of the AA2 Cell Line
during the Period of Study
derivatives in the presence ofOKT4A. AA2, which does undergo fusion and shows
variable expression ofCD4, bound about 1 .5-fold more gp120than the otherWI-L2
lines; and this binding was inhibited -20% by OKT4A.
Despite the failure to detect either CD4 expression or OKT4A-inhibitable gp120
binding by the 107 andBdCK B cell lines, productive infection of these lines, and
ofCEM4, by HTLV-IIIB was completely blocked by OKT4A; their infection was
delayedby theOKT4 antibody (Fig . 5) . Infection ofAA2 wasonly delayedbyOKT4A
and was notdetectably affected by OKT4 . The remarkable efficiency ofHTLVIIIB
replication in AA2 is indicated in this experiment by both the more rapid kinetics
of infection and the production of 100-fold more p24 protein by AA2 thanCEM.
FIGURE 4.
￿
OKT4A inhibition ofthe
binding of 115I-labeled gp120 to cell
lines .
Month
Reverse
transcriptase
Max cpm
-
Leu3
Antibody
OKT4
Percent cells
reactivity
OKT4A
positive
DR
1 206,900 - - 8 95
3 - 89 - - 95
6 251,800 - - - -
8 350,800 12 8 6 75
12 339,500 - 68 63 87
13 350,500 57 45 35 79
19 345,400 6 1 .4 0 .5 75CHAFFEE ET AL.
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￿
Effect ofOKT4 and
OKT4A mAbs on p24 produc-
tion of HTLVIIIB-infected cell
lines. Aliquots ofcultures ofthe
indicated cell lines containing
105 cells were centrifuged and
resuspended in growth medium
containing no added antibody
(control) or containing 1 gg/ml
of OKT4 or OKT4A mAbs.
After 2 h, each culture was in-
fected with 0.1 ml of a standard
stock of HTLVIIIB. After an-
other 24 h cells were centri-
fuged, washed and resuspended
in fresh medium without virus
and lacking (control) or con-
taining the appropriate anti-
body (1 ug/ml). On the fourth
day after infection all cultures
were fed with 1 ml of fresh
medium lacking antibody. On
days 5 and 7 afterinfection, ali-
quots of 0.4 ml were removed
from each culture for assay of
p24 by ELISA, and the cultures
were fed with the same volume
ofmedium lackingantibody. A
final 0.4 ml sample for p24 assay
was removed on day 10.
Discussion
The diversity ofin vitro responses to HIV among clonal derivatives ofthe CEM
T and WIL-2 B cell lines is striking. Several fairly distinct patterns could be distin-
guished, based on the ability to support replication of HIV and sensitivity to its
cytopathic effects (Table V discussedbelow). These phenotypes were stable andwhere
it was evaluated, the phenotypes ofsubclones of the same strain were similar. The
set ofphenotypes expressed by CEM and WIL-2 derivatives overlapped, but were
not identical. Takentogether, thevarious phenotypic combinations expressedbyCEM-
and WIL-2-derived cell lines clearly indicate a dissociation of HIV replication and
the two characteristic cytopathic effects of the virus. Moreover, our results empha-
size that while expression ofthe CD4 protein is necessary for HIV infection, other
host cell factors can play a dominant role in determining the outcome ofinfection.
All strains of CEM that were permissive (P+) for HTLVIIIB (i.e., supported
production ofhigh levels ofvirion-associated RT activity and p24 core protein), were
sensitive to viral cytopathic effect (C+), as measured by loss of viability after ex-
posure to free virus. All permissive (P+) strains of CEM underwent rapid fusion
(F+) to form multinucleate syncytia when placed in contact with HIVinfected cells,
another C134-dependent manifestation of HIV cytopathic effect (29-33). The con-
verse correlation of C and F phenotypes did not hold among nonpermissive (P-)
GEM strains: AC0611a was P-C- and F- , but two other P-C- strains of GEM
were F+. In contrast to the P'C' F+ phenotype ofpermissive CEM strains, two per-
missive derivatives ofWIL-2, 107, and BdCK were insensitive to both cytopathic
effects: they were not killed after infection by free HTLVIIIB and they did not un-616
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TABLE V
Host Cell-HIV Phenotypes Observed among Strains of CEM T and WIL-2
B lymphoblastoid Cell Lines
Cell lines
￿
Phenotype*
CEM-derived
GEM
￿
P' C' F' CD4'
CEM4
￿
P' C' F' CD4'
Ml-la
￿
P' C' F' CD4'
AC0611a
￿
P- C- F- CD4'
GEM St. Jude
￿
P- C- F'CD4`
dCK- St. Jude
￿
P- C- F'CD4'
WIL-2 derived
WIL-2
￿
P- C- F- CD4=
BdCK
￿
P' C- F- CD4}
107
￿
P'C- F- CD4±
K2B
￿
P' C ± F'CD4'-
AA2
￿
P`C' F'CD4± ,'
* P, permissive: P+ , >5 x background in RT assay, P- , <5 x background. C- ,
cytopathic effect: C' , >75 % of cells killed; C- <15% decrease in viability
compared with uninfected control. F, fusion: F', scores >3 + in standard syn-
cytium assay (see Materials and Methods); F- , no fusion; F:1 , scores <2 + .
CD4, reactivity with T4A monoclonal antibody: CD4', >35 % of cells react ;
CD4- , near level ofdetectability by indirect immunolluorescence FAGS anal-
ysis (-<10% of cells react).
dergo fusion (P+C-F- phenotype). On the other hand, AA2, another HIV
permissive WIL-2-derived cell line, was rapidly killed by the virus and did undergo
fusion (P+C+F+ phenotype).
How does this complexity relate to current understandingof the role ofCD4 ex-
pression as a determinant ofHIV sensitivity? The CD4 antigen, through interac-
tion with the glycosylated (13, 32) gp120 envelope protein ofHIV, acts as a receptor
for free HIV on a subset ofT cells, and on cells induced to express CD4 bytransfer
oftheCD4cDNA(1, 2, 4, 24-28). CD4 expression isalso necessaryforHIV-induced
cell fusion (29-33). Although HIV preferentially infects CD4+ T cells, it also in-
fects cells ofdifferent lineages, including monocytes and macrophages (6, 34-39),
B lymphocytes (6, 8, 39, 40), promyelocytes (6), and cells ofneural origin (41-43).
CD4 can be expressed by these cell lines (4, 6, 35, 44, 45), but whether HIV only
infects cells ofthese lineages that express CD4, or whetherother receptors, or other
modes ofcell entry, are involved is unclear. Moreover, the relationship between the
level ofCD4 expression and susceptibility to infection by HIV is complex. For ex-
ample, Levy et al. (6) found that the level ofLeu-3 expression did not always corre-
late with production of HIV in a study of unrelated cell lines. Independently iso-
lated clones ofthe Molt-4 T cell line varied in their susceptibility to infection by
HIV while expressing similar levels of the CD4 antigen (7). Salahuddin et al. (8)
observed that mAbs to the CD4 antigen incompletely blocked infection of B cell
lines by HIV.
In the present studies we found that some WIL-2-derived strains were permissive
for HTLV-IIIB, even though they expressed nearly undetectable levels of CD4 byCHAFFEE ET AL.
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indirect immunofluorescence FACS analysis, and exhibited noOKT4A-inhibitable
gp120 binding. Nevertheless, the fact that OKT4A completely blocked their infec-
tion by HTLVIIIB indicates that CD4 is essential for infection. It is clear that the
level ofCD4necessary forinfection ofthese permissive WIL-2 strains (and perhaps
other non-T cells) can be very low, perhaps on the order ofa few hundred or a few
thousand molecules per cell. Conversely, the findingthat some nonpermissive (P- )
CEM strains expressed similar high levels of CD4 and bound similar amounts of
gp120 as permissive strains ofCEM, isevidence thatCD4 expression is notsufficient
for productive HIV infection.
Some P- CEM strains were able to undergo fusion with HIVinfected cells, sug-
gesting a block in infection at a stage after virus entry. On the other hand, the in-
ability ofthe P- CEM strain AC0611a to undergo fusion, despite its ability to ex-
press CD4 andbind gp120, suggeststhat some host cellmembrane component, other
than CD4, is involved in virus entry and the fusion process. It is intriguing that
this host cell phenotype can be mimicked by specific mutations in HIV env gene
sequences encoding the hydrophobic NH2 terminus of gp41, the transmembrane
virus envelope protein (28). Expression ofthese mutant env genes yielded gp120 that
was indistinguishable from wild type and bound to CD4+ lymphocytes normally,
but was unable to induce cell fusion (28). It is possible that AC0611a is altered in
a host cell membrane component that interacts with gp41 to mediate a step in virus
entry and cell fusion that follows gpl20-CD4 binding.
The levelofCD4 expression by AA2 cells ranged from <57o to>80% ofcells during
a 20-mo period ofobservation. The basis for this variable expression of CM is not
known, but neither the susceptibility ofAA2 to HIV infection, nor the time course
ofinfection, changed over this period. Thelevel ofexpression ofCD4does not seem
tobe a sufficient explanation forthe sensitivity ofthiscell line to infection by HTLV
IIIB. AA2 can produce up to two orders ofmagnitude more virus than CEM and
exhibits a marked cytopathic effect within 3-5 d, compared with 8-10 d for CEM.
Thisremarkablesensitivitysuggeststhe operationofhostcell factorsthatcan powerfully
potentiate HIV replication, or alternatively a defect in, or suppression of, a host
orviral gene productthat normally would inhibit viral gene expression orviral repli-
cation.
The AA2 cell line appears to be significantly more susceptible to HIV infection
than many T and B cell lines that have been reported as being particularly sensitive
to strains ofHIV. For example, X50-7, an EBVtransformed B cellline thatexpresses
CD4 on60-70% ofcells, exhibits acytopathic effect within 15 d (46). A3.01, a HAT
sensitive derivative of CEM, showed maximal RT activity at 10 d after infection,
coincident with cell death (47), which is similar to the time course we observe with
our CEM4 clone. The ATH8 T cell line exhibits a cytopathic effect within 4 d of
infection by HTLVIIB, but it requires IL-2 for growth and is HTLVI transformed
(48). The ease ofculturing AA2 cells and its sensitivity to HIV infection make AA2
potentially useful for producing high titer stocks of HIV and for isolation of HIV
from clinical samples. A subclone ofAA (AA5) with comparable characteristics to
AA2 has been used as an indicator strain in a rapid, colorimetric assay for HIV
neutralizing antibody that depends on killing gf infected cells (23). In the case of
AA2, "growthrough"survivors ofHTLVIIIB infection do notactively producevirus
(data not presented) . We are investigating the ability ofother derivatives of CEM61 8
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and WIL-2 to serve as chronic virus producers in the manner of the H9 T cell line
(19) or the FR8 EBVtransformed B cell line (39).
Clearly, further work will be required to determine the basis for the host cell-virus
interactions displayed by the cells we have studied (Table V), but this report may
provide some direction for future investigation. It would, for example, be of interest
to use these cell lines to examine HIV replication intermediates and gene expres-
sion, and the expression ofHIV constructs bearing defined mutations in virus-encoded
regulatory elements. The identification ofnucleoside kinase-deficient mutants capable
of supporting HIV replication provides a panel ofcells that will be useful for studying
the mechanism of activation and metabolism of nucleosideanalogs with antiretroviral
activity. We would encourage the use of this panel of cell lines for studies aimed
at identifying and isolating host factors and genes that play important roles in deter-
mining the outcome of HIV infection.
Summary
Derivatives of the CEM T and WIL-2 B cell lines showed striking diversity in
their responses to the HTLVIIIB strain ofthe human immunodeficiency virus (HIV).
Several stable phenotypic patterns could be defined, based on whether cells were
permissive (P+, P- ) for virus production, were sensitive or insensitive to cytopathic
effects after infection by free virus (C + , C- ), and whether they underwent fusion
on contact with virus-infected cells (F+, F- ). Although expression of CD4 was es-
sential for infection by HTLVIIIB, very low levels were sufficient for productive
infection of WIL-2 derivatives. Conversely, some CEM T cell lines that expressed
ample CD4, and which were able to bind virus gp120 and undergo fusion, did not
support productive infection by free virus. One nonpermissive, CD4' derivative of
CEM could bind gp120 but failed to undergo fusion, suggesting an alteration in some
membrane protein other than CD4 that is essential for virus entry and HIV-induced
cell fusion. The AA2 derivative of the WIL-2 cell line is also described, which is
remarkably permissive for HIV replication and exquisitely sensitive to virus cytopathic
effect. The panel of related cell lines with different host-virus phenotypes could be
useful for more precisely defining steps in the infectious cycle of HIV, and for iden-
tifying host cell genes and gene products that determine the outcome ofHIV infection.
We appreciate the expert technical assistance of Ms. Setrina Hunter and Ms. Charlene
McDanal.
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